CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 949 enrolled
Drug / intervention
Accu Chek Inform and Cobas IT 1000device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00486681
NCT00486681N/ACompleted
CompareCT.gov

Evaluation of the Implementation of the Accu-Chek Inform Cobas IT 1000 System in Three Medical Hospital Departments: Impact on the Management of Diabetes

University Hospital, Grenoble·observational·Posted Jun 15, 2007·Updated Mar 4, 2008

In Brief

An observational study evaluating Accu Chek Inform and Cobas IT 1000 for Diabetes Mellitus and 3 related conditions. Completed, enrolled 949 participants across 1 site.

Detailed Summary

The principal objective of this single-center 2-period study is to evaluate the glycemic control of in-patients in 3 hospital departments (Diabetology, Cardiology and Pulmonary Care) as the rate of capillary blood glucose measurements within a pre-define target range, and to compare results during the period I (warning of the Accu-Check Inform glucose meter on glucose levels not activated) and period II (warning activated).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Blood Glucose, Hospital Information Systems, Medical Device
CountriesFrance
CollaboratorsRoche Diagnostics Meylan France, Assistance Medico-Technique A Domicile

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 15, 2007
Enrollment StartJan 1, 2007
Primary CompletionJul 1, 2007
Study CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 19.0 years ago

Interventions

Accu Chek Inform and Cobas IT 1000device

period II (warning activated)